New DG Sanco structure effective as of next month: what does it mean for medtech?
This article was originally published in Clinica
Executive Summary
The European Commission’s Directorate General Health and Consumers (DG Sanco) is undergoing a restructuring so that it is able to respond more readily to the introduction of innovative healthcare solutions. The reorganisation will also allow for better management of public health issues separately from health systems and products, through the introduction of a new directorate.